Breaking News From Pharma & Bio Ingredients Subscribe via RSS Subscribe via RSS



Watson Data Shows Prostate Drug Works


Posted on 2007-01-16 07:48:00



Drug maker Watson Pharmaceuticals Inc. said Tuesday that early data in two clinical trials show that its enlarged prostate treatment was effective.

The company said clinical trials of silodosin for benign prostatic hyperplasia met primary and secondary endpoints while showing the drug was well tolerated. Benign prostatic hyperplasia is an enlarged prostate without cancer.

Patients given silodosin over 12 weeks showed statistically significant improvement in the obstruction and irritation caused by their enlarged prostate glands compared with placebo. Patients also saw improvement in the flow of their urine.

The company plans to wrap up a one-year safety study on the drug in the fall, and submit a marketing application with the Food and Drug Administration in the first half of 2008.


NEWS ARCHIVES

2008

2007

2006

2005

2004

NEWSLETTER SIGNUP